Cell and Gene therapies are life-changing new medicines whose full potential is only just beginning to emerge. They are cutting-edge and rapidly progressing fields of Biological Therapies. These advanced therapies aim to treat, prevent or potentially cure diseases and both approaches offer the potential to diminish the fundamental cause of genetic and acquired diseases by substituting the missing protein or cells causing the disease’s symptoms.

The two-day Congress will provide an interactive, cutting edge, and comprehensive discussions in collaborative format led by key experts with intimate knowledge in the industry. Gain practical strategies and best practices on challenges, innovations, technologies, and concepts to help you gain access to the booming CGT market.

Speaking from Cell and Gene Therapy Catapult:

Talk: 23rd October, 14:35 - 'Non-Clinical Risk Assessment and Strategy - A case study'

Description: This talk will introduce the development of novel gene therapies, pivotal non-clinical studies and discuss the relevant non-clinical considerations within the context of a case study of a novel gene therapy.

Speaking: Mark Singh, Non-clinical Manager